Skip to search formSkip to main contentSkip to account menu

VBAP protocol

Known as: BCNU/DOX/PRED/VCR, Carmustine/Doxorubicin/Prednisone/Vincristine, VBAP 
National Institutes of Health

Related topics

Related topics

7 relations

Broader (3)

Antineoplastic Combined Chemotherapy ProtocolsCarmustinecisplatin/cyclophosphamide/etoposide protocol
DoxorubicinDoxorubicin HydrochloridePrednisoneVincristine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Multichannel audio rendering using amplitude panning [DSP Applications]
Spatial audio is a field that investigates techniques to reproduce spatial attributes of sound (e.g., direction, distance, width… 
2002
2002
Comparative evaluation of safety and efficacy of pamidronate and zoledronic acid in multiple myeloma patients (single center experience).
Osteolytic bone destruction, caused by the aberrant production and activation of osteoclasts, results in significant morbidity… 
Highly Cited
2001
Highly Cited
2001
Increased conventional chemotherapy does not improve survival in multiple myeloma: long-term results of two PETHEMA trials including 914 patients.
BACKGROUND Melphalan and prednisone (MP) has been the standard treatment for multiple myeloma (MM) for the last 30 years… 
1998
1998
Maintenance treatment with interferon alpha-2b in multiple myeloma: a prospective randomized study from PETHEMA (Program for the Study and Treatment of Hematological Malignancies, Spanish Society of…
The objectives of the present study were to investigate whether interferon alpha (IFN) maintenance could prolong response… 
1997
1997
Conventional induction treatments do not influence overall survival in multiple myeloma
A retrospective analysis was performed on two subsequent myeloma patient series treated with the same conventional induction… 
Review
1994
Review
1994
Standard treatment of multiple myeloma.
Highly Cited
1993
Highly Cited
1993
Alternating combination VCMP/VBAP chemotherapy versus melphalan/prednisone in the treatment of multiple myeloma: a randomized multicentric study of 487 patients.
PURPOSE To determine whether combination chemotherapy with alternating cycles of vincristine, cyclophosphamide, melphalan, and… 
Highly Cited
1990
Highly Cited
1990
Chemotherapy is superior to sequential hemibody irradiation for remission consolidation in multiple myeloma: a Southwest Oncology Group study.
Six hundred fourteen previously untreated patients with multiple myeloma were evaluated on this phase III Southwest Oncology… 
1989
1989
Alternating combination chemotherapy (VMCP/VBAP) is not superior to melphalan/prednisone in the treatment of multiple myeloma patients stage III —A randomized study from MGCS
86 previously untreated patients with multiple myeloma stage III entered a randomized trial comparing combination chemotherapy… 
Highly Cited
1986
Highly Cited
1986
Improved survival duration with combination chemotherapy induction for multiple myeloma: a Southwest Oncology Group Study.
Four hundred forty previously untreated patients with active multiple myeloma were entered into a randomized trial (Southwest… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)